Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Nov;17(9):2977-85.
doi: 10.1007/s10461-013-0510-4.

Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women

Kathryn Curran  1 , Nelly R Mugo, Ann Kurth, Kenneth Ngure, Renee Heffron, Deborah Donnell, Connie Celum, Jared M Baeten
Affiliations
Randomized Controlled Trial

Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women

Kathryn Curran et al. AIDS Behav. 2013 Nov.

Abstract

Pre-exposure prophylaxis (PrEP) is a novel HIV prevention strategy which requires high adherence. We tested the use of daily short message service (i.e., SMS/text message) surveys to measure sexual behavior and PrEP adherence in Kenya. Ninety-six HIV-uninfected adult individuals, taking daily oral PrEP in a clinical trial, received daily SMS surveys for 60 days. Most participants (96.9 %) reported taking PrEP on ≥80 % days, but 69.8 % missed at least one dose. Unprotected sex was reported on 4.9 % of days; however, 47.9 % of participants reported unprotected sex at least once. Unprotected sex was not correlated with PrEP use (OR = 0.95). Participants reporting more sex were less likely to report PrEP non-adherence and those reporting no sex were most likely to report missing a PrEP dose (adjusted OR = 1.87). PrEP adherence was high, missed doses were correlated with sexual abstinence, and unprotected sex was not associated with decreased PrEP adherence.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of participant enrollment, survey distribution, and response rates. The target sample size for this study was 100. Study staff approached Partners PrEP clinical trial participants for enrollment during their monthly clinic visits. Some participants had already completed maximum follow-up for the Partners PrEP Study clinical trial at the time this pilot evaluation was conducted. A total of 110 participants were enrolled in the study, of which 96 participants responded to ≥5 of 7 daily surveys during the 1st week run-in. Of 5,760 surveys planned for 96 participants over 60 days, 5,412 surveys were distributed, 32 surveys were cancelled after one participant exited due to pregnancy, and 316 surveys were not delivered due to a mid-study block by a local mobile phone provider
See this image and copyright information in PMC

References

    1. Karim AQ, Karim ASS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74. - PMC - PubMed
    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410. - PMC - PubMed
    1. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34. - PubMed
    1. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012;26(7):F13–9. - PubMed
    1. Donnell D, Baeten J, Hendrix C, Bumpus N, Bangsberg D, Haberer J, et al. Tenofovir Disoproxil Fumarate drugs levels indicate PrEP use is strongly correlated with HIV-1 protective effects: Kenya and Uganda. 19th conference on retroviruses and opportunistic infections; Seattle. 2012. paper 30.

Publication types

Substances